<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="of repeated vaccination using 10-year vaccination history on protection against" exact="influenza" post="in older adults: a test-negative design study across the"/>
 <result pre="adults: a test-negative design study across the 2010/11 to 2015/16" exact="influenza" post="seasons in Ontario, Canada Kwong Jeffrey C 1 2"/>
 <result pre="licence, and indicate if changes were made. Abstract Introduction Annual" exact="influenza" post="vaccination is recommended for older adults, but evidence regarding"/>
 <result pre="been inconclusive. Aim We investigated vaccine effectiveness (VE) against laboratory-confirmed" exact="influenza" post="and the impact of repeated vaccination over 10 previous"/>
 <result pre="episodes for respiratory viruses, with 11,496 (20%) testing positive for" exact="influenza" post="and 31,004 (53%) vaccinated. Adjusted VE against laboratory-confirmed influenza"/>
 <result pre="for influenza and 31,004 (53%) vaccinated. Adjusted VE against laboratory-confirmed" exact="influenza" post="for the six seasons combined was 21% (95% confidence interval"/>
 <result pre="previous vaccinations, current season vaccination likely provides some protection against" exact="influenza" post="regardless of the number of vaccinations received over the"/>
 <result pre="of the number of vaccinations received over the previous 10" exact="influenza" post="seasons. Keywords: Influenza vaccine vaccine effectiveness repeated vaccination older"/>
 <result pre="risk of severe outcomes [ 1]. In this age group," exact="influenza" post="vaccines are 24–63% effective in preventing laboratory-confirmed influenza ["/>
 <result pre="age group, influenza vaccines are 24–63% effective in preventing laboratory-confirmed" exact="influenza" post="[ 2- 4]. Due to frequent changes in circulating"/>
 <result pre="in the 1970s at a British boarding school found higher" exact="influenza" post="incidence among students who had received multiple previous vaccines"/>
 <result pre="objectives of this study were to estimate VE against laboratory-confirmed" exact="influenza" post="infection in community-dwelling older adults for the 2010/11 to"/>
 <result pre="aged &amp;gt; 65 years in Ontario (2016 population aged ≥ 65 years: 2.3 million) who were tested for" exact="influenza" post="during inpatient or outpatient healthcare encounters between 1 September"/>
 <result pre="September 2010 and 31 August 2016. Details regarding these six" exact="influenza" post="seasons have been reported previously [ 19]. We used"/>
 <result pre="physician services, hospital care, diagnostic testing, prescription medications, and trivalent" exact="influenza" post="vaccines during the study. We estimated VE using the"/>
 <result pre="VE using the test-negative design, which compares the odds of" exact="influenza" post="vaccination among laboratory-confirmed influenza cases and test-negative controls ["/>
 <result pre="design, which compares the odds of influenza vaccination among laboratory-confirmed" exact="influenza" post="cases and test-negative controls [ 20]. Ethical statement Ethics"/>
 <result pre="of the following viruses: adenovirus, bocavirus, coronavirus, enterovirus/rhinovirus, human metapneumovirus," exact="influenza" post="A, influenza B, parainfluenza virus, and respiratory syncytial virus"/>
 <result pre="following viruses: adenovirus, bocavirus, coronavirus, enterovirus/rhinovirus, human metapneumovirus, influenza A," exact="influenza" post="B, parainfluenza virus, and respiratory syncytial virus [ 19]."/>
 <result pre="same season, we included their earliest testing episode positive for" exact="influenza" post="(or their earliest testing episode if all specimens tested"/>
 <result pre="presenting with acute respiratory illnesses (ARI) who were tested for" exact="influenza" post="varied by setting (22.1% for inpatients, 2.5% for patients"/>
 <result pre="offices) [ 19]. Since only 49% of individuals positive for" exact="influenza" post="A had their specimens subtyped, we assessed their generalisability"/>
 <result pre="by comparing the characteristics of those with subtyped and unsubtyped" exact="influenza" post="A specimens ( Supplementary Table S2). Information on lineage"/>
 <result pre="A specimens ( Supplementary Table S2). Information on lineage for" exact="influenza" post="B was not available. Healthcare encounter data We identified"/>
 <result pre="for those with provincial health insurance. Influenza vaccination We ascertained" exact="influenza" post="vaccination status using physician and (starting in 2012, when"/>
 <result pre="in 2012, when a policy change permitted pharmacists to administer" exact="influenza" post="vaccines) pharmacist billing claims, maintained in the OHIP and"/>
 <result pre="determined the presence of comorbidities that increase the risk of" exact="influenza" post="complications (anaemia, cancer, cardiovascular disease, dementia, diabetes, frailty, immunodeficiency"/>
 <result pre="comorbidities that increase the risk of influenza complications (anaemia, cancer," exact="cardiovascular disease," post="dementia, diabetes, frailty, immunodeficiency due to underlying disease and/or"/>
 <result pre="effectiveness We used logistic regression to estimate VE, against laboratory-confirmed" exact="influenza" post="infection, by comparing the odds of vaccination in the"/>
 <result pre="presence of any comorbidity, calendar time (month of test), and" exact="influenza" post="season (except when estimating VE by season). These variables"/>
 <result pre="for the province to restrict the analyses to periods when" exact="influenza" post="was circulating. We estimated VE against any influenza and"/>
 <result pre="periods when influenza was circulating. We estimated VE against any" exact="influenza" post="and each influenza type/subtype for the 2010/11 to 2015/16"/>
 <result pre="was circulating. We estimated VE against any influenza and each" exact="influenza" post="type/subtype for the 2010/11 to 2015/16 seasons combined and"/>
 <result pre="were tested by PCR. Third, since Ontario residents may receive" exact="influenza" post="vaccines in settings besides physician offices and pharmacies (leading"/>
 <result pre="publicly available macro [ 21] to correct for misclassification of" exact="influenza" post="vaccination status using previously reported parameters for sensitivity (69%)"/>
 <result pre="previously reported parameters for sensitivity (69%) and specificity (90%) of" exact="influenza" post="vaccination codes for older adults in Ontario health administrative"/>
 <result pre="impact of repeated vaccination on current season VE against any" exact="influenza" post="and each influenza type/subtype for the 2010/11 to 2015/16"/>
 <result pre="vaccination on current season VE against any influenza and each" exact="influenza" post="type/subtype for the 2010/11 to 2015/16 seasons combined. We"/>
 <result pre="longer vaccination history durations (i.e. one, five, and 10 previous" exact="influenza" post="seasons). Since influenza vaccination data in Ontario are more"/>
 <result pre="durations (i.e. one, five, and 10 previous influenza seasons). Since" exact="influenza" post="vaccination data in Ontario are more accurate among those"/>
 <result pre="tested during multiple seasons), with 11,496 (20%) testing positive for" exact="influenza" post="and 31,004 (53%) vaccinated during the season of testing"/>
 <result pre="found in Supplementary Table S4. Overall adjusted VE against any" exact="influenza" post="for the 2010/11 to 2015/16 seasons combined was 21%"/>
 <result pre="against A(H3N2), and 30% (95%CI: 24 to 36%) against B. VE against unsubtyped" exact="influenza" post="A viruses was only 11% (95%CI: 5 to 16%). We observed substantial"/>
 <result pre="by PCR ( Table 1 ). VE estimates stratified by" exact="influenza" post="subtype and season are presented in Supplementary Table S5."/>
 <result pre="vaccine effectiveness estimates for community-dwelling adults aged &amp;gt; 65 years, 2010/11 to 2015/16" exact="influenza" post="seasons in Ontario, Canada (n = 58,304) a Analysis Test-positive patients"/>
 <result pre="b 5,575/11,496 25,429/46,808 21 (18 to 24) 21 (18 to 24) 38 (35 to 42) By" exact="influenza" post="type/subtype Influenza A c A(H3N2) 1,780/3,765 25,429/46,808 25 (19 to 29)"/>
 <result pre="B 1,027/2,138 25,429/46,808 22 (15 to 29) 30 (24 to 36) 42 (37 to 49) By" exact="influenza" post="season 2010/11 488/1,204 2,561/4,980 36 (27 to 43) 33 (23 to 41) 54"/>
 <result pre="in the past year, comorbidities that increase the risk of" exact="influenza" post="complications (anaemia, cancer, cardiovascular disease, dementia, diabetes, frailty, immunodeficiency"/>
 <result pre="comorbidities that increase the risk of influenza complications (anaemia, cancer," exact="cardiovascular disease," post="dementia, diabetes, frailty, immunodeficiency due to underlying disease and/or"/>
 <result pre="well as renal disease and respiratory disease), calendar time, and" exact="influenza" post="season. b For any influenza, 2010/11 to 2015/16 influenza"/>
 <result pre="and influenza season. b For any influenza, 2010/11 to 2015/16" exact="influenza" post="seasons combined. c Only 49% of influenza A specimens"/>
 <result pre="2010/11 to 2015/16 influenza seasons combined. c Only 49% of" exact="influenza" post="A specimens were subtyped. d PCR (monoplex or multiplex)."/>
 <result pre="characteristics of community-dwelling adults aged &amp;gt; 65 years for the 2010/11 to 2015/16" exact="influenza" post="seasons, stratified by vaccination history for the previous season,"/>
 <result pre="mean ± SD 16.5 ± 9.3 NA 17.4 ± 9.1 NA 15.4 ± 9.5 NA &amp;lt; 0.001 Month of" exact="influenza" post="testing November 1,407 2.4 785 2.4 622 2.5 0.83"/>
 <result pre="49,621 85.5 28,544 85.9 21,077 85.1 0.007 Specimen positive for" exact="influenza" post="11,444 19.7 6,177 18.6 5,267 21.3 &amp;lt; 0.001 Vaccinated against"/>
 <result pre="influenza 11,444 19.7 6,177 18.6 5,267 21.3 &amp;lt; 0.001 Vaccinated against" exact="influenza" post="in current season 30,916 53.3 24,592 74.0 6,324 25.5"/>
 <result pre="applicable; SD: standard deviation. a Includes acute ischaemic stroke, arrhythmias," exact="congestive heart failure," post="ischaemic heart disease, and transient ischaemic attack. Table 3"/>
 <result pre="a Includes acute ischaemic stroke, arrhythmias, congestive heart failure, ischaemic" exact="heart disease," post="and transient ischaemic attack. Table 3 Descriptive characteristics of"/>
 <result pre="of community-dwelling adults aged ≥ 70 years for the 2010/11 to 2015/16" exact="influenza" post="seasons, stratified by influenza vaccination history over five previous"/>
 <result pre="years for the 2010/11 to 2015/16 influenza seasons, stratified by" exact="influenza" post="vaccination history over five previous seasons, Ontario, Canada (n = 49,294)"/>
 <result pre="NA 17.5 ± 8.8 NA 16.8 ± 9.2 NA 13.7 ± 9.0 NA &amp;lt; 0.001 Month of" exact="influenza" post="testing November 1,178 2.4 590 2.4 380 2.4 208"/>
 <result pre="21,487 87.1 13,767 86.4 7,398 85.1 &amp;lt; 0.001 Specimen positive for" exact="influenza" post="9,877 20.0 4,743 19.2 3,117 19.6 2,017 23.2 &amp;lt; 0.001"/>
 <result pre="20.0 4,743 19.2 3,117 19.6 2,017 23.2 &amp;lt; 0.001 Vaccinated against" exact="influenza" post="in current season 27,043 54.9 18,946 76.8 7,325 46.0"/>
 <result pre="applicable; SD: standard deviation. a Includes acute ischaemic stroke, arrhythmias," exact="congestive heart failure," post="ischaemic heart disease, and transient ischaemic attack. Table 4"/>
 <result pre="a Includes acute ischaemic stroke, arrhythmias, congestive heart failure, ischaemic" exact="heart disease," post="and transient ischaemic attack. Table 4 Descriptive characteristics of"/>
 <result pre="characteristics of community-dwelling adults aged ≥ 75 years for the 2010/11 to 2015/16" exact="influenza" post="seasons, stratified by influenza vaccination history over 10 previous"/>
 <result pre="aged ≥ 75 years for the 2010/11 to 2015/16 influenza seasons, stratified by" exact="influenza" post="vaccination history over 10 previous seasons, Ontario, Canada (n = 38,766)"/>
 <result pre="NA 16.8 ± 9.0 NA 15.4 ± 8.8 NA 13.1 ± 8.8 NA &amp;lt; 0.001 Month of" exact="influenza" post="testing November 908 2.3 286 2.2 232 2.6 161"/>
 <result pre="6,511 87.8 4,449 86.4 3,595 86.4 0.01 Specimen positive for" exact="influenza" post="8,043 20.7 2,653 20.4 1,783 19.8 1,502 20.3 1,095"/>
 <result pre="19.8 1,502 20.3 1,095 21.3 1,010 24.3 &amp;lt; 0.001 Vaccinated against" exact="influenza" post="in current season 21,645 55.8 10,297 79.0 5,847 64.9"/>
 <result pre="applicable; SD: standard deviation. a Includes acute ischaemic stroke, arrhythmias," exact="congestive heart failure," post="ischemic heart disease, and transient ischaemic attack. Figure 1"/>
 <result pre="a Includes acute ischaemic stroke, arrhythmias, congestive heart failure, ischemic" exact="heart disease," post="and transient ischaemic attack. Figure 1 Forest plots of"/>
 <result pre="plots of (A) current season vaccine effectiveness estimates against any" exact="influenza" post="for community-dwelling adults aged &amp;gt; 65 years, taking into account vaccination histories"/>
 <result pre="S1) but not against A(H1N1)pdm09 ( Supplementary Figure S2) or" exact="influenza" post="B ( Supplementary Figure S3). When correcting for misclassification"/>
 <result pre="S6). When accounting for 5-year vaccination history, significant protection against" exact="influenza" post="was observed among patients with any previous vaccination, with"/>
 <result pre="this study of older adults, we estimated VE against laboratory-confirmed" exact="influenza" post="healthcare use to be 21% (95%CI: 18 to 24%) during the 2010/11"/>
 <result pre="use to be 21% (95%CI: 18 to 24%) during the 2010/11 to 2015/16" exact="influenza" post="seasons, which increased to 38% (95%CI: 35 to 42%) after correcting for"/>
 <result pre="When we examined the impact of repeated vaccination during previous" exact="influenza" post="seasons on VE for the current season, we observed"/>
 <result pre="in VE as the number of previous vaccinations increased. Nevertheless," exact="influenza" post="vaccination during the current season was associated with some"/>
 <result pre="during the current season was associated with some protection against" exact="influenza" post="infection irrespective of the number of vaccinations over the"/>
 <result pre="correcting for misclassification of vaccination status in the current season," exact="influenza" post="vaccination was associated with some protection even for those"/>
 <result pre="seasons based on current season misclassification. Similar patterns as any" exact="influenza" post="were observed against A(H3N2) but not A(H1N1)pdm09 or influenza"/>
 <result pre="any influenza were observed against A(H3N2) but not A(H1N1)pdm09 or" exact="influenza" post="B, but interpretation of these results is challenging due"/>
 <result pre="analyses leading to less precision. The observed patterns for any" exact="influenza" post="were likely driven by A(H3N2) since that subtype comprised"/>
 <result pre="A(H3N2) since that subtype comprised 67% of specimens during the" exact="influenza" post="seasons included in this study, if one assumes the"/>
 <result pre="that vaccination in the current season provided some protection against" exact="influenza" post="regardless of the number of previous vaccinations. No study"/>
 <result pre="vaccinated for the first time if they were infected by" exact="influenza" post="in the prior season. Vaccine responses may be enhanced"/>
 <result pre="for potential vaccine interference. Future studies that longitudinally ascertain both" exact="influenza" post="vaccination and influenza infection status over multiple seasons would"/>
 <result pre="interference. Future studies that longitudinally ascertain both influenza vaccination and" exact="influenza" post="infection status over multiple seasons would be helpful to"/>
 <result pre="to underestimation of VE. Third, the VE estimate against unsubtyped" exact="influenza" post="A was outside of the range between those against"/>
 <result pre="of potential bias. Although only 49% of individuals positive for" exact="influenza" post="A had their specimens subtyped, they are fairly representative"/>
 <result pre="subtyped, they are fairly representative of all individuals positive for" exact="influenza" post="A ( Supplementary Table S1). We speculate that the"/>
 <result pre="season with known poor match) and during later months of" exact="influenza" post="season (with potentially lower VE due to intra-season waning"/>
 <result pre="VE due to intra-season waning of immunity). Fourth, receipt of" exact="influenza" post="vaccines outside of physician offices and pharmacies leads to"/>
 <result pre="in our sensitivity analyses. The low sensitivity value for the" exact="influenza" post="vaccination billing claims used in these sensitivity analyses may"/>
 <result pre="immunological interactions. Eighth, we did not have information on participants’" exact="influenza" post="infections in the previous seasons, as most infections do"/>
 <result pre="we did not have information on vaccination history for &amp;gt; 10 previous" exact="influenza" post="seasons; the impact of repeated vaccination over longer periods"/>
 <result pre="older adults in Ontario, Canada during the 2010/11 to 2015/16" exact="influenza" post="seasons. We observed declining VE associated with repeated vaccination,"/>
 <result pre="vaccination, however current season vaccination likely provides some protection against" exact="influenza" post="regardless of the number of vaccines received over the"/>
 <result pre="of the number of vaccines received over the previous 10" exact="influenza" post="seasons. Moreover, among those not vaccinated in the current"/>
 <result pre="increasing numbers of previous vaccines received. Therefore, until effective universal" exact="influenza" post="vaccines are available and eliminate the need for annual"/>
 <result pre="influenza vaccines are available and eliminate the need for annual" exact="influenza" post="vaccination, our findings support current recommendations for annual vaccination"/>
 <result pre="JP Sundaram ME Kelley NS Osterholm MT et al. Variable" exact="influenza" post="vaccine effectiveness by subtype: a systematic review and meta-analysis"/>
 <result pre="Thompson MG Levêque A Moren A Sullivan SG Effectiveness of" exact="influenza" post="vaccines in preventing severe influenza illness among adults: A"/>
 <result pre="A Sullivan SG Effectiveness of influenza vaccines in preventing severe" exact="influenza" post="illness among adults: A systematic review and meta-analysis of"/>
 <result pre="MJ Hak E van den Heuvel ER Effectiveness of seasonal" exact="influenza" post="vaccine in community-dwelling elderly people: a meta-analysis of test-negative"/>
 <result pre="A Assessment of inactivated influenza-A vaccine after three outbreaks of" exact="influenza" post="A at Christ’s Hospital. Lancet. 1979; 313( 8106): 33-"/>
 <result pre="LL Hess KR Efficacy of repeated annual immunization with inactivated" exact="influenza" post="virus vaccines over a five year period. Vaccine. 1997;"/>
 <result pre="S Ackley DH Perelson AS Variable efficacy of repeated annual" exact="influenza" post="vaccination. Proc Natl Acad Sci USA. 1999; 96( 24):"/>
 <result pre="O’Donnell J et al. Exploring the effect of previous inactivated" exact="influenza" post="vaccination on seasonal influenza vaccine effectiveness against medically attended"/>
 <result pre="Exploring the effect of previous inactivated influenza vaccination on seasonal" exact="influenza" post="vaccine effectiveness against medically attended influenza: Results of the"/>
 <result pre="The Working Group Of The Project Pi/ The effectiveness of" exact="influenza" post="vaccination in preventing hospitalisations of elderly individuals in two"/>
 <result pre="influenza vaccination in preventing hospitalisations of elderly individuals in two" exact="influenza" post="seasons: a multicentre case-control study, Spain, 2013/14 and 2014/15."/>
 <result pre="HQ Chambers C Sundaram ME De Serres G Repeated annual" exact="influenza" post="vaccination and vaccine effectiveness: review of evidence. Expert Rev"/>
 <result pre="Hylton DA Zhang YB Malhotra D et al. Does consecutive" exact="influenza" post="vaccination reduce protection against influenza: A systematic review and"/>
 <result pre="Kwong JC et al. The impact of repeated vaccination on" exact="influenza" post="vaccine effectiveness: a systematic review and meta-analysis. BMC Med."/>
 <result pre="et al. Impact of repeated vaccination on vaccine effectiveness against" exact="influenza" post="A(H3N2) and B during 8 seasons. Clin Infect Dis."/>
 <result pre="Å Brytting M Leval A Hergens MP Impact of repeated" exact="influenza" post="vaccinations in persons over 65 years of age: A large"/>
 <result pre="65 years of age: A large population-based cohort study of severe" exact="influenza" post="over six consecutive seasons, 2011/12-2016/17. Vaccine. 2018; 36( 37):"/>
 <result pre="collected laboratory and health administrative data be used to assess" exact="influenza" post="vaccine effectiveness? Assessing the validity of the Flu and"/>
 <result pre="20 Jackson ML Nelson JC The test-negative design for estimating" exact="influenza" post="vaccine effectiveness. Vaccine. 2013; 31( 17): 2165- 8. 10.1016/j.vaccine.2013.02.053"/>
 <result pre="claims from the Ontario Health Insurance Plan to determine individual" exact="influenza" post="vaccination status: an updated validation study. CMAJ Open. 2016;"/>
 <result pre="al. Serial vaccination and the antigenic distance hypothesis: Effects on" exact="influenza" post="vaccine effectiveness during A(H3N2) epidemics in Canada, 2010-2011 to"/>
 <result pre="predictor of immunity in the face of natural challenge with" exact="influenza" post="viruses. Epidemiol Infect. 1989; 102( 2): 325- 33. 10.1017/S0950268800030004"/>
 <result pre="et al. collab: Marshfield Influenza Study Group Effectiveness of inactivated" exact="influenza" post="vaccines varied substantially with antigenic match from the 2004-2005"/>
</results>
